国际中医中药杂志
國際中醫中藥雜誌
국제중의중약잡지
INTERNATIONAL JOURNAL OF TRIDITIONAL CHINESE MEDICINE
2009年
6期
542-543
,共2页
肠易激综合征%社会支持%治疗依从性%生活质量
腸易激綜閤徵%社會支持%治療依從性%生活質量
장역격종합정%사회지지%치료의종성%생활질량
Irritable bowel syndrome%Social support%Treatment compliance%The quality of li
目的 探讨社会支持程度对肠易激综合征(irritable bowel syndrome,IBS)患者中西医结合治疗依从性、疗效及生活质量的影响.方法 符合Rome Ⅱ诊断标准的IBS患者,共67例.治疗6周后,按社会支持总评分情况分组,<35分为低社会支持组(低分组),>45分为高社会支持组(高分组).分别进行治疗依从性、世界卫生组织生存质量测定量表简表(WHOQCL-BREF)、临床疗效比较,并进行统计学处理.结果 SSRS高分组治疗依从性为(13.79±5.12)分、低分组为(11.25±4.28)分,高分组的治疗依从性高于低分组(t=2.01.P<0.05).高分组WHOQCL-BREF生理领域、心理领域、社会关系领域、环境领域评分均高于低分组(P<0.05或<0.01).高分组临床显效、有效及总有效率均高于低分组,差异有统计学意义(P<0.05).社会的主观支持、客观支持、支持利用度因子,与治疗依从性及WHOQCL-BREF除环境领域外的各因子成显著正相关(P<0.05或0.01):WHOQCL-BREF环境领域因子仅与客观支持有相关性(P<0.05).结论 良好而有效的社会支持,对提高IBS患者治疗依从性、生活质量、及临床疗效具有重要的意义.
目的 探討社會支持程度對腸易激綜閤徵(irritable bowel syndrome,IBS)患者中西醫結閤治療依從性、療效及生活質量的影響.方法 符閤Rome Ⅱ診斷標準的IBS患者,共67例.治療6週後,按社會支持總評分情況分組,<35分為低社會支持組(低分組),>45分為高社會支持組(高分組).分彆進行治療依從性、世界衛生組織生存質量測定量錶簡錶(WHOQCL-BREF)、臨床療效比較,併進行統計學處理.結果 SSRS高分組治療依從性為(13.79±5.12)分、低分組為(11.25±4.28)分,高分組的治療依從性高于低分組(t=2.01.P<0.05).高分組WHOQCL-BREF生理領域、心理領域、社會關繫領域、環境領域評分均高于低分組(P<0.05或<0.01).高分組臨床顯效、有效及總有效率均高于低分組,差異有統計學意義(P<0.05).社會的主觀支持、客觀支持、支持利用度因子,與治療依從性及WHOQCL-BREF除環境領域外的各因子成顯著正相關(P<0.05或0.01):WHOQCL-BREF環境領域因子僅與客觀支持有相關性(P<0.05).結論 良好而有效的社會支持,對提高IBS患者治療依從性、生活質量、及臨床療效具有重要的意義.
목적 탐토사회지지정도대장역격종합정(irritable bowel syndrome,IBS)환자중서의결합치료의종성、료효급생활질량적영향.방법 부합Rome Ⅱ진단표준적IBS환자,공67례.치료6주후,안사회지지총평분정황분조,<35분위저사회지지조(저분조),>45분위고사회지지조(고분조).분별진행치료의종성、세계위생조직생존질량측정량표간표(WHOQCL-BREF)、림상료효비교,병진행통계학처리.결과 SSRS고분조치료의종성위(13.79±5.12)분、저분조위(11.25±4.28)분,고분조적치료의종성고우저분조(t=2.01.P<0.05).고분조WHOQCL-BREF생리영역、심리영역、사회관계영역、배경영역평분균고우저분조(P<0.05혹<0.01).고분조림상현효、유효급총유효솔균고우저분조,차이유통계학의의(P<0.05).사회적주관지지、객관지지、지지이용도인자,여치료의종성급WHOQCL-BREF제배경영역외적각인자성현저정상관(P<0.05혹0.01):WHOQCL-BREF배경영역인자부여객관지지유상관성(P<0.05).결론 량호이유효적사회지지,대제고IBS환자치료의종성、생활질량、급림상료효구유중요적의의.
Objective To investigate the effect of the degree of social support on treatment compliance, efficacy and quality of life in patients with irritable bowel syndrome. Methods A total of 67 patients diagnosed of Rome II irritable bowel syndrome (IBS) were recruited into a low social support group (<35) and a high social support group (>45) according to the total score of social support. Treatment compliance, the World Health Organization Quality of Life BREF Determination (WHOQCL-BREF) and the clinical efficacy respectively were measured and compared between the two groups. Results The treatment compliance of patients with IBS in SSRS high score group was (13.79±5.12). While the treatment compliance of IBS patients in SSRS low score group was (11.25± 4.28). The difference between the two groups was significant (t=2.01, P<0.05).WHOQCL-BREF physical field, psychological field, social relations field and the environment field of IBS patients in SSRS high score group were significantly higher than the SSRS low score group (P<0.05) . Obvious effective rate, effective rate, and total effective rate in SSRS high score group were also higher than the low SSRS score group, with a significant difference (P<0.05) . The subjective Support, objective support, support availability factors of social support have significantly positive correlations (P<0.05 or 0.01) with the treatment compliance and all WHOQCL-BREF factors except environment; WHOQCL-BREF environmental factor was only related with the objective support (P<0.05) . Conclusion A good effective social support is of great significance in improving treatment compliance , quality of life and clinical efficacy in patients with IBS.
